Stock Ideas
New
Stocks
Funds
Screener
Sectors
Watchlists

Latest venBio Partners LLC Stock Portfolio

$281Million

Equity Portfolio Value
Last Reported on: 15 May, 2024

About venBio Partners LLC and it’s 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, venBio Partners LLC reported an equity portfolio of $281.9 Millions as of 31 Mar, 2024.

The top stock holdings of venBio Partners LLC are ALXO, PHVS, HRMY. The fund has invested 38.4% of it's portfolio in ALX ONCOLOGY HLDGS INC and 35.2% of portfolio in PHARVARIS N V.

The fund managers got completely rid off RAYZEBIO INC and IMPEL PHARMACEUTICALS INC (IMPL) stocks. They significantly reduced their stock positions in PHARVARIS N V (PHVS) and ELEVATION ONCOLOGY INC (ELEV).

New Buys

No new stocks were added by venBio Partners LLC

Additions

No additions were made to existing positions by venBio Partners LLC

Reductions

Ticker% Reduced
PHARVARIS N V-12.81
ELEVATION ONCOLOGY INC-7.48

venBio Partners LLC reduced stake in above stock

Sold off

Ticker$ Sold
RAYZEBIO INC-320,683,000
IMPEL PHARMACEUTICALS INC-340,834

venBio Partners LLC got rid off the above stocks

Current Stock Holdings of venBio Partners LLC

Last Reported on: 15 May, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions
ALXOALX ONCOLOGY HLDGS INC38.379,699,920108,154,000UNCHANGED0.00
ELEVELEVATION ONCOLOGY INC4.912,696,13013,831,200REDUCED-7.48
HRMYHARMONY BIOSCIENCES HLDGS IN12.331,035,40034,768,600UNCHANGED0.00
IMPLIMPEL PHARMACEUTICALS INC0.000.000.00SOLD OFF-100
PHVSPHARVARIS N V35.164,289,30099,125,800REDUCED-12.81
ACELYRIN INC9.223,852,47026,004,200UNCHANGED0.00
RAYZEBIO INC0.000.000.00SOLD OFF-100